Amedeo Smart

Free Medical Literature Service



Chronic Renal Failure

  Free Subscription

Articles published in
Kidney Int
    September 2018
  1. SHAIKH M, Woodward M, John O, Bassi A, et al
    Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
    Kidney Int. 2018;94:440-445.
    >> Share

    August 2018
    Is the peritoneal dialysis biocompatibility hypothesis dead?
    Kidney Int. 2018;94:246-248.
    >> Share

    July 2018
  3. JHA V, Modi GK
    Getting to know the enemy better-the global burden of chronic kidney disease.
    Kidney Int. 2018 Jul 24. pii: S0085-2538(18)30362.
    >> Share

  4. YAMADA S, Leaf EM, Chia JJ, Cox TC, et al
    PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.
    Kidney Int. 2018 Jul 21. pii: S0085-2538(18)30389.
    >> Share

  5. FUKAGAWA M, Shimazaki R, Akizawa T
    Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30387.
    >> Share

  6. XIE Y, Bowe B, Mokdad AH, Xian H, et al
    Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.
    Kidney Int. 2018 Jul 5. pii: S0085-2538(18)30318.
    >> Share

    The analysis of hemoglobin A1c in dialysis patients should include the variables that reflect the erythrocyte turnover.
    Kidney Int. 2018;94:220-221.
    >> Share

  8. RAYNER HC, Rosansky SJ
    The estimated glomerular filtration rate graph: another tool in the management of patients with advanced chronic kidney disease.
    Kidney Int. 2018;94:222.
    >> Share

    Protein carbamylation: a key driver of vascular calcification during chronic kidney disease.
    Kidney Int. 2018;94:12-14.
    >> Share

    June 2018
  10. WANNER C, Herzog CA, Turakhia MP
    Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2018 Jun 20. pii: S0085-2538(18)30358.
    >> Share

  11. KARABOYAS A, Xu H, Morgenstern H, Locatelli F, et al
    DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
    Kidney Int. 2018 Jun 13. pii: S0085-2538(18)30253.
    >> Share

  12. HU JR, Coresh J, Inker LA, Levey AS, et al
    Serum metabolites are associated with all-cause mortality in chronic kidney disease.
    Kidney Int. 2018 Jun 2. pii: S0085-2538(18)30247.
    >> Share

  13. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    >> Share

  14. WYATT CM, Wanner N
    Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults.
    Kidney Int. 2018;93:1260-1262.
    >> Share

    May 2018
  15. RABY AC, Gonzalez-Mateo GT, Williams A, Topley N, et al
    Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30254.
    >> Share

  16. DURLACHER-BETZER K, Hassan A, Levi R, Axelrod J, et al
    Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30240.
    >> Share

  17. TAM-THAM H, Quinn RR, Weaver RG, Zhang J, et al
    Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.
    Kidney Int. 2018 May 23. pii: S0085-2538(18)30246.
    >> Share

  18. ALEKSOVA J, Wong P, McLachlan R, Choy KW, et al
    Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30212.
    >> Share

  19. SCHAEFER B, Bartosova M, Macher-Goeppinger S, Sallay P, et al
    Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30213.
    >> Share

  20. ALRIC L, Ollivier-Hourmand I, Berard E, Hillaire S, et al
    Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30209.
    >> Share

  21. NG DK, Schwartz GJ, Schneider MF, Furth SL, et al
    Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30184.
    >> Share

  22. GOODKIN DA, Bieber B
    International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
    Kidney Int. 2018;93:1249.
    >> Share

  23. FUSARO M, Cannata-Andia JB, Nickolas TL, Plebani M, et al
    Clinical relevance and future perspective of fractures in patients with chronic kidney disease.
    Kidney Int. 2018;93:1248.
    >> Share

    Uncovering real mortality trends in ESRD patients.
    Kidney Int. 2018;93:1040-1043.
    >> Share

    April 2018
  25. NEVEN E, Vervaet B, Brand K, Gottwald-Hostalek U, et al
    Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30174.
    >> Share

  26. BARUTTA F, Bruno G, Mastrocola R, Bellini S, et al
    The role of cannabinoid signaling in acute and chronic kidney diseases.
    Kidney Int. 2018 Apr 26. pii: S0085-2538(18)30140.
    >> Share

  27. BRUCK K, Jager KJ, Zoccali C, Bello AK, et al
    Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30096.
    >> Share

  28. KALRA PA, Green D, Poulikakos D
    Arrhythmia in hemodialysis patients and its relation to sudden death.
    Kidney Int. 2018;93:781-783.
    >> Share

  29. LABRIOLA L, Jadoul M
    Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered.
    Kidney Int. 2018;93:1015-1016.
    >> Share

  30. MATHEW RO, Bangalore S, Sidhu MS, Fleg JL, et al
    Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Kidney Int. 2018;93:787-788.
    >> Share

  31. WATERS DD, Vogt L
    Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
    Kidney Int. 2018;93:784-786.
    >> Share

    Update on renal blood oxygenation level-dependent MRI to assess intrarenal oxygenation in chronic kidney disease.
    Kidney Int. 2018;93:778-780.
    >> Share

    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    >> Share

  34. OOMATIA A, Dupont P, Bass P, Moochhala S, et al
    The Case | Shining a light on an unusual case of chronic kidney disease.
    Kidney Int. 2018;93:1023-1024.
    >> Share

    March 2018
  35. GRAMS ME, Sang Y, Ballew SH, Carrero JJ, et al
    Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
    Kidney Int. 2018 Mar 24. pii: S0085-2538(18)30097.
    >> Share

  36. VERVLOET MG, van Ballegooijen AJ
    Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Kidney Int. 2018 Mar 23. pii: S0085-2538(18)30124.
    >> Share

  37. WANG J, Zhang L, Tang SC, Kashihara N, et al
    Disease burden and challenges of chronic kidney disease in North and East Asia.
    Kidney Int. 2018 Mar 21. pii: S0085-2538(18)30094.
    >> Share

  38. PUN PH, Wyatt CM
    Utility of implantable cardioverter defibrillators in chronic kidney disease.
    Kidney Int. 2018 Mar 17. pii: S0085-2538(18)30196.
    >> Share

  39. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    >> Share

  40. TOTH PP, Dwyer JP, Cannon CP, Colhoun HM, et al
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Kidney Int. 2018 Mar 8. pii: S0085-2538(18)30055.
    >> Share

  41. TONELLI M, Wiebe N, James MT, Klarenbach SW, et al
    A population-based cohort study defines prognoses in severe chronic kidney disease.
    Kidney Int. 2018 Mar 7. pii: S0085-2538(18)30057.
    >> Share

    February 2018
  42. RABBANI N, Thornalley PJ
    Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30051.
    >> Share

  43. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    >> Share

  44. SUMIDA K, Molnar MZ, Potukuchi PK, Hassan F, et al
    Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30893.
    >> Share

  45. NITSCH D
    Does dialysis modality affect the development of cognitive impairment?
    Kidney Int. 2018;93:306-308.
    >> Share

  46. DUSSO A, Colombo MI, Shanahan CM
    Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.
    Kidney Int. 2018;93:298-301.
    >> Share

  47. ORDUNEZ P, Hoy WE
    Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.
    Kidney Int. 2018;93:284-287.
    >> Share

    January 2018
  48. STOREY BC, Staplin N, Harper CH, Haynes R, et al
    Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Kidney Int. 2018 Jan 30. pii: S0085-2538(17)30856.
    >> Share

  49. ROY-CHAUDHURY P, Tumlin JA, Koplan BA, Costea AI, et al
    Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30855.
    >> Share

  50. DOU L, Poitevin S, Sallee M, Addi T, et al
    Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30826.
    >> Share

  51. LIU BC, Tang TT, Lv LL, Lan HY, et al
    Renal tubule injury: a driving force toward chronic kidney disease.
    Kidney Int. 2018 Jan 17. pii: S0085-2538(17)30819.
    >> Share

  52. PRUIJM M, Milani B, Pivin E, Podhajska A, et al
    Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30800.
    >> Share

  53. LEE BJ, Go AS, Parikh R, Leong TK, et al
    Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30797.
    >> Share

  54. PERSSON F, Borg R
    YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
    Kidney Int. 2018;93:21-22.
    >> Share

    Intensive hemodialysis-keeping the faith.
    Kidney Int. 2018;93:10-12.
    >> Share

  56. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.
    >> Share

  57. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.
    >> Share

  58. FARRAH TE, Anand A, Miller-Hodges E, Mills NL, et al
    Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.
    Kidney Int. 2018;93:270.
    >> Share

    December 2017
  59. YU ASL, Shen C, Landsittel DP, Harris PC, et al
    Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Kidney Int. 2017 Dec 28. pii: S0085-2538(17)30785.
    >> Share

  60. ANDERS HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, et al
    The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30772.
    >> Share

  61. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    >> Share

  62. Moradi H, Said HM. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016;90:252-254.
    Kidney Int. 2017;92:1558.
    >> Share

  63. Li L, Lai EY, Luo Z, et al. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Kidney Int. 2017;92:625-633.
    Kidney Int. 2017;92:1558.
    >> Share

  64. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26-36.
    Kidney Int. 2017;92:1558.
    >> Share

  65. ISAKA Y
    Adaptor protein is a new therapeutic target in chronic kidney disease.
    Kidney Int. 2017;92:1312-1314.
    >> Share

    November 2017
  66. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    >> Share

    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    >> Share

  68. LIN TY, Peng CH, Hung SC, Tarng DC, et al
    Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30663.
    >> Share

    October 2017
  69. SAWINSKI D, Forde KA, Locke JE, Cohen JB, et al
    Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
    Kidney Int. 2017 Oct 26. pii: S0085-2538(17)30612.
    >> Share

  70. NEUMANN D, Mau W, Wienke A, Girndt M, et al
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Kidney Int. 2017 Oct 14. pii: S0085-2538(17)30568.
    >> Share

  71. CHARYTAN DM, Skali H, Shah NR, Veeranna V, et al
    Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Kidney Int. 2017 Oct 13. pii: S0085-2538(17)30571.
    >> Share

  72. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    >> Share

  73. STREJA E
    Hospital readmission for the dialysis patient: who is (not) responsible?
    Kidney Int. 2017;92:788-790.
    >> Share

    September 2017
  74. PIMENTEL A, Urena-Torres P, Zillikens MC, Bover J, et al
    Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Kidney Int. 2017 Sep 27. pii: S0085-2538(17)30567.
    >> Share

  75. LORENZ G, Schmalenberg M, Kemmner S, Haller B, et al
    Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
    Kidney Int. 2017 Sep 20. pii: S0085-2538(17)30540.
    >> Share

  76. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    >> Share

  77. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    >> Share

    July 2017
  78. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    >> Share

    April 2017
  79. BIERZYNSKA A, McCarthy HJ, Soderquest K, Sen ES, et al
    Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Kidney Int. 2017;91:937-947.
    >> Share

    March 2017
  80. LOWENSTEIN J, Grantham JJ
    Residual renal function: a paradigm shift.
    Kidney Int. 2017;91:561-565.
    >> Share

  81. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    >> Share

    February 2017
  82. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    >> Share

  83. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    >> Share

  84. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    >> Share

    November 2016
  85. READY AR, Nath J, Milford DV, Adu D, et al
    Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Kidney Int. 2016;90:916-920.
    >> Share

    August 2016
  86. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.
    >> Share

    July 2016
  87. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    >> Share

    April 2016
  88. GILL J, Dong J, Rose C, Gill JS, et al
    The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Kidney Int. 2016 Apr 5. pii: S0085-2538(16)00324.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016